Abstract| Volume 21, SUPPLEMENT 3, S150, November 2020

Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

      This paper is only available as a PDF. To read, Please Download here.